Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cidara Therapeutics (CDTX) Current Leases: 2019-2024

Historic Current Leases for Cidara Therapeutics (CDTX) over the last 6 years, with Dec 2024 value amounting to $1.4 million.

  • Cidara Therapeutics' Current Leases rose 18.00% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year increase of 18.00%. This contributed to the annual value of $1.4 million for FY2024, which is 27.36% up from last year.
  • As of FY2024, Cidara Therapeutics' Current Leases stood at $1.4 million, which was up 27.36% from $1.1 million recorded in FY2023.
  • In the past 5 years, Cidara Therapeutics' Current Leases ranged from a high of $1.4 million in FY2024 and a low of $939,000 during FY2020.
  • Its 3-year average for Current Leases is $1.2 million, with a median of $1.2 million in 2022.
  • Per our database at Business Quant, Cidara Therapeutics' Current Leases declined by 10.65% in 2023 and then rose by 27.36% in 2024.
  • Cidara Therapeutics' Current Leases (Yearly) stood at $939,000 in 2020, then grew by 22.26% to $1.1 million in 2021, then climbed by 5.49% to $1.2 million in 2022, then declined by 10.65% to $1.1 million in 2023, then increased by 27.36% to $1.4 million in 2024.